Deloitte Integrates Patient Engagement Solution with Apple to Improve Adherence to Treatment Plans
Deloitte, today announced it has integrated its ConvergeHEALTH Patient Connect product with Apple HealthKit, CareKit and ResearchKit frameworks, enabling patients to improve adherence to treatment plans while supporting connectivity to clinical research. This is the latest in a series of innovative additions to the ConvergeHEALTH product portfolio. ConvergeHEALTH is a group of products engineered and built by Deloitte to enable life sciences clients to respond to the shift to value-based, personalized medicine. By integrating with ConvergeHEALTH Patient Connect, life sciences innovators have an opportunity to engage and support patients in new ways.
In addition, Deloitte is expanding its Apple practice, a dedicated team of health care app developers in the Deloitte Digital studios. “This dedicated team of UI, UX and iOS engineers will specialize in developing health care-specific digital apps to transform the patient experience,” said Mike Brinker, global Deloitte Digital leader and principal, Deloitte Consulting LLP.
“Patients’ expectations for more personalized services are one of the driving forces behind health care’s overall transformation toward more patient-centric care models. By integrating ConvergeHEALTH Patient Connect, which supports 300,000 patients globally, with Apple’s health frameworks, care coordinators can better manage their patient population by proactively engaging with their patients using their Apple devices and meeting those growing patient expectations,” said Chris Zant, life sciences global digital and patient engagement leader, and principal, Deloitte Consulting LLP.